Hannes Hagström
Hannes Hagström
Verifierad e-postadress på ki.se
Titel
Citeras av
Citeras av
År
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
M Ekstedt, H Hagström, P Nasr, M Fredrikson, P Stål, S Kechagias, ...
Hepatology 61 (5), 1547-1554, 2015
13242015
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis
PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ...
Hepatology 65 (5), 1557-1565, 2017
7542017
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis
G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ...
PLoS Med 11 (7), e1001680, 2014
4152014
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, R Hultcrantz, ...
Journal of hepatology 67 (6), 1265-1273, 2017
4102017
Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
RS Taylor, RJ Taylor, S Bayliss, H Hagström, P Nasr, JM Schattenberg, ...
Gastroenterology 158 (6), 1611-1625. e12, 2020
1022020
Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long‐term follow‐up study
H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, R Hultcrantz, ...
Hepatology communications 2 (1), 48-57, 2018
912018
Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis
C Efe, H Hagström, H Ytting, RA Bhanji, NF Müller, Q Wang, T Purnak, ...
Clinical Gastroenterology and Hepatology 15 (12), 1950-1956. e1, 2017
692017
Overweight in late adolescence predicts development of severe liver disease later in life: a 39 years follow-up study
H Hagström, P Stål, R Hultcrantz, T Hemmingsson, A Andreasson
Journal of hepatology 65 (2), 363-368, 2016
622016
High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men
H Hagström, P Tynelius, F Rasmussen
Gut 67 (8), 1536-1542, 2018
542018
Adverse outcomes of pregnancy in women with non‐alcoholic fatty liver disease
H Hagström, J Höijer, JF Ludvigsson, M Bottai, A Ekbom, R Hultcrantz, ...
Liver International 36 (2), 268-274, 2016
522016
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
GJ Webb, T Marjot, JA Cook, C Aloman, MJ Armstrong, EJ Brenner, ...
The Lancet Gastroenterology & Hepatology 5 (11), 1008-1016, 2020
422020
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
H Hagström, P Nasr, M Ekstedt, S Kechagias, K Önnerhag, E Nilsson, ...
Scandinavian journal of gastroenterology 52 (2), 159-165, 2017
422017
Cardiovascular risk factors in non‐alcoholic fatty liver disease
H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, J Askling, R Hultcrantz, ...
Liver International 39 (1), 197-204, 2019
372019
Elevated serum ferritin is associated with increased mortality in non‐alcoholic fatty liver disease after 16 years of follow‐up
H Hagström, P Nasr, M Bottai, M Ekstedt, S Kechagias, R Hultcrantz, ...
Liver International 36 (11), 1688-1695, 2016
372016
Alcohol consumption in late adolescence is associated with an increased risk of severe liver disease later in life
H Hagström, T Hemmingsson, A Discacciati, A Andreasson
Journal of hepatology 68 (3), 505-510, 2018
352018
Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis: results from a nationwide Swedish population
TG Simon, AS Duberg, S Aleman, H Hagstrom, LH Nguyen, H Khalili, ...
Annals of internal medicine 171 (5), 318-327, 2019
322019
Alcohol consumption in concomitant liver disease: how much is too much?
H Hagström
Current hepatology reports 16 (2), 152-157, 2017
322017
Ability of noninvasive scoring systems to identify individuals in the population at risk for severe liver disease
H Hagström, M Talbäck, A Andreasson, G Walldius, N Hammar
Gastroenterology 158 (1), 200-214, 2020
292020
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
B Bengtsson, P Stål, S Wahlin, NK Björkström, H Hagström
Liver International 39 (6), 1098-1108, 2019
282019
Accuracy of noninvasive scoring systems in assessing risk of death and liver-related endpoints in patients with nonalcoholic fatty liver disease
H Hagström, P Nasr, M Ekstedt, P Stål, R Hultcrantz, S Kechagias
Clinical Gastroenterology and Hepatology 17 (6), 1148-1156. e4, 2019
272019
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20